Joint Venture26 Nov 2024, 08:17 pm
Akums Drugs and Pharmaceuticals Ltd Enters Exclusive Master Sales Agreement with Caregen Co., Ltd
AI Summary
Akums Drugs and Pharmaceuticals Ltd, an Indian company, has entered into an exclusive Master Sales Agreement with Caregen Co., Ltd, a leading South Korean company in the Nutraceuticals segment. Akums has been granted the exclusive rights to sell certain Caregen products range in India during the term of the agreement. The company will also undertake the packaging, marketing and selling of Caregen’s line of bulk product under the Caregen’s trademark or Akums’s trademark or of Akums’s Clients trademark.
Key Highlights
- Akums Drugs and Pharmaceuticals Ltd has entered into an exclusive Master Sales Agreement with Caregen Co., Ltd
- Akums has been granted the exclusive rights to sell certain Caregen products range in India
- The agreement also includes the packaging, marketing and selling of Caregen’s line of bulk product under the Caregen’s trademark or Akums’s trademark or of Akums’s Clients trademark
- Caregen is a global leader in peptide research and development and a global biotechnology company based in South Korea
- The agreement is effective for Five (05) years from the signing date